Dr. Conroy L. Chow, MD

Dr. Chow practices at Loma Linda University Faculty Medical Group - Dermatology in Loma Linda, California.

Dr. Chow's NPI, 1508151556, was assigned on June 17, 2011. Dr. Chow graduated from University Of Michigan Medical School in 2011. Dr. Chow holds California license A136034.

Dr. Chow's primary practice is Loma Linda University Faculty Medical Group - Dermatology, at 25865 Barton Rd, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-3636.

Dr. Chow's primary practice is Loma Linda University Faculty Medical Group - Dermatology in Loma Linda, California. Dr. Chow is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Chow to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chow practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Chow's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Chow is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Chow's licenses on file in 2 states: California and Michigan.

CMS data shows 1,333 Medicare services from Dr. Chow across 26 procedure codes in 2024, for 349 Medicare patients. Medicare paid $297,333 for them. Every service was in an office.

CMS counts 349 Medicare patients who saw Dr. Chow in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chow's median patient age at 72, with 45% women.

In 2024, Dr. Chow wrote 362 Medicare Part D claims for 196 patients. 83% of them were for generic drugs. CMS names the drug for 277 of them, across 8 drugs with 11 or more claims each, at $9,086 in total drug cost. In 2023, CMS named 272 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Chow for performance year 2024, reported as part of a group. Dr. Chow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chow as offering telehealth. CMS counts 80 procedures of melanoma (skin cancer) excision by Dr. Chow, more than 91% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Chow, published from 2016 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Dermatology, Mohs Surgery and Skin Neoplasms. Dr. Chow has published most often in Int J Dermatol. Dr. Chow's most frequent co-authors are Ashley N. Elsensohn, MD, Nancy J. Anderson, MD and Sarah Tuttleton Arron, MD, PhD.

Dmand AI links Dr. Chow to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous.

CMS Open Payments shows 2 general payments to Dr. Chow from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $125.

Dr. Chow graduated from University Of Michigan Medical School in 2011.

Dr. Chow is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.